Literature DB >> 17985761

Evaluation of data obtained from military disability medical administrative databases for service members with schizophrenia or bipolar disorder.

Amy M Millikan1, Natalya S Weber, David W Niebuhr, E Fuller Torrey, David N Cowan, Yuanzhang Li, Brenda Kaminski.   

Abstract

OBJECTIVE: We are studying associations between selected biomarkers and schizophrenia or bipolar disorder among military personnel. To assess potential diagnostic misclassification and to estimate the date of illness onset, we reviewed medical records for a subset of cases.
METHODS: Two psychiatrists independently reviewed 182 service medical records retrieved from the Department of Veterans Affairs. Data were evaluated for diagnostic concordance between database diagnoses and reviewers. Interreviewer variability was measured by using proportion of agreement and the kappa statistic. Data were abstracted to estimate date of onset.
RESULTS: High levels of agreement existed between database diagnoses and reviewers (proportion, 94.7%; kappa = 0.88) and between reviewers (proportion, 92.3%; kappa = 0.87). The median time between illness onset and initiation of medical discharge was 1.6 and 1.1 years for schizophrenia and bipolar disorder, respectively.
CONCLUSIONS: High levels of agreement between investigators and database diagnoses indicate that diagnostic misclassification is unlikely. Discharge procedure initiation date provides a suitable surrogate for disease onset.

Entities:  

Mesh:

Year:  2007        PMID: 17985761     DOI: 10.7205/milmed.172.10.1032

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  3 in total

1.  Monocyte activation detected prior to a diagnosis of schizophrenia in the US Military New Onset Psychosis Project (MNOPP).

Authors:  Natalya S Weber; Kristin L Gressitt; David N Cowan; David W Niebuhr; Robert H Yolken; Emily G Severance
Journal:  Schizophr Res       Date:  2018-01-06       Impact factor: 4.939

2.  Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset.

Authors:  M K Chan; M-O Krebs; D Cox; P C Guest; R H Yolken; H Rahmoune; M Rothermundt; J Steiner; F M Leweke; N J M van Beveren; D W Niebuhr; N S Weber; D N Cowan; P Suarez-Pinilla; B Crespo-Facorro; C Mam-Lam-Fook; J Bourgin; R J Wenstrup; R R Kaldate; J D Cooper; S Bahn
Journal:  Transl Psychiatry       Date:  2015-07-14       Impact factor: 6.222

3.  Results from a hypothesis generating case-control study: herpes family viruses and schizophrenia among military personnel.

Authors:  David W Niebuhr; Amy M Millikan; Robert Yolken; Yuanzhang Li; Natalya S Weber
Journal:  Schizophr Bull       Date:  2007-12-21       Impact factor: 9.306

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.